CAPECITABINE , BEVACIZUMAB , PANITUMUMAB, CETUXIMAB, FLUOROURACIL , CALCIUM LEVOFOLINATE clinical trials

Phase II study evaluating Holmium-166 TARE followed by maIntenance Therapy in liver limited unresectable colorectal cancer patients after first-lIne chemotherapy and target agents: The HAITI study.

This study looks at a new way to treat bowel cancer that has spread only to the liver and can't be removed with surgery. It combines a special radiation treatment with regular cancer medicines to see if it can stop the cancer from growing for longer. It's for adults who have already had some chemotherapy.